LSTA: the balance sheet

MyFinsight

For the year ending 2025-12-31, LSTA has $17,744K in assets. $3,143K in debts. $15,956K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	15,956
Marketable securities	0
Accounts receivable	0
Prepaid and other current assets	1,747
Total current assets	17,703
Property and equipment, net	18
Acquired license-intangible, net	0
Other assets	23
Total assets	17,744

Accounts payable	1,019
Accrued liabilities	2,052
Total current liabilities	3,071
Other long-term liabilities	72
Total liabilities	3,143
Common stock, 0.001 par value, authorized 500,000,000 shares issued 8,834,613 and 8,409,582 shares, at december 31, 2025 and december 31, 2024, respectively and outstanding, 8,833,875 and 8,408,844 shares, at december 31, 2025 and december 31, 2024, respectively	9
Additional paid-in capital	580,243
Treasury stock, at cost 738 shares at december 31, 2025 and december 31, 2024 respectively	708
Accumulated deficit	-564,652
Accumulated other comprehensive loss	-37
Total lisata therapeutics, inc. stockholders' equity	14,855
Non-controlling interests	-254
Total equity	14,601
Total liabilities, non-controlling interests and stockholders' equity	17,744

Unit: Thousand (K) dollars (except for numbers of shares and EPS).